Procter & Gamble Co. buy BNP Paribas Exane
Start price
27.09.25
/
50%
€130.46
Target price
27.09.26
€146.97
Performance (%)
-6.75%
Price
12.12.25
€121.66
Summary
This prediction is currently active. With a performance of -6.75%, the BUY prediction for Procter & Gamble Co. by BNP_Paribas_Exane is down slightly. This prediction currently runs until 27.09.26. The prediction end date can be changed by BNP_Paribas_Exane at any time. BNP_Paribas_Exane has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Procter & Gamble Co. | -1.202% | -1.202% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by BNP_Paribas_Exane for this prediction
In the thread Procter & Gamble Co. diskutieren
Procter & Gamble (NYSE:PG) had its price target lowered by analysts at BNP Paribas Exane from $177.00 to $172.00. They now have an "outperform" rating on the stock.
Ratings data for PG provided by MarketBeat